Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DYHI06
|
|||
| Drug Name |
CLBS16
|
|||
| Drug Type |
Cell therapy
|
|||
| Indication | Coronary microvascular disease [ICD-11: BA86] | Phase 2 | [1] | |
| Company |
Caladrius Biosciences
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT03508609) An Open-Label Exploratory Clinical Study to Evaluate the Safety and Potential Bioactivity of CLBS16 in Patients With Coronary Microvascular Dysfunction (CMD) and Without Obstructive Coronary Artery Disease. U.S.National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.